Clinical Trial Update: Combining Esketamine and Prolonged Exposure Treatment for PTSD (Post Traumatic Stress Disorder) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial tested esketamine in combination with prolonged exposure therapy for post-traumatic stress disorder. The study, conducted at UT Healt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Esketamine (esketamine)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Post Traumatic Stress Disorder PTSD | Phase 1, Phase 2 | Status: COMPLETED